Hematology TimesStudy reveals ‘complete mental health’ among cancer survivorsAugust 24, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated Issues
Hematology TimesDrug receives priority review for second MM indicationAugust 24, 2018Multiple Myeloma
Hematology TimesAccess to care drives disparity between urban, rural cancer patientsAugust 20, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated IssuesAMLNon-Hodgkin LymphomaAggressive Lymphomas
Hematology NewsHaving prescription drug coverage is associated with improved myeloma outcomesAugust 16, 2018Practice ManagementMultiple MyelomaLymphoma & Plasma Cell DisordersBusiness of Medicine
Hematology NewsLenalidomide best option for myeloma maintenance therapyAugust 15, 2018Multiple MyelomaLeukemia, Myelodysplasia, Transplantation
Hematology TimesStudy links communication, outcomes in cancerAugust 15, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated Issues
Hematology TimesAuto-HSCT linked to higher AML, MDS riskAugust 14, 2018AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaTransplantationAMLMyelodysplastic Syndrome
Hematology NewsJanssen seeks approval for split dosing of daratumumabAugust 9, 2018Multiple MyelomaLymphoma & Plasma Cell Disorders
